Bill > S2710

This bill expands the existing Open Payments reporting requirements under the Social Security Act to include mandatory disclosure of financial contributions made by pharmaceutical and medical device manufacturers to patient advocacy organizations. Starting March 31, 2027, and annually thereafter, manufacturers must submit electronic reports to the Secretary of Health and Human Services detailing any "covered payments" to such organizations, which include direct and indirect monetary transfers or other valuable contributions. A patient advocacy organization is defined as a 501(c)(3) tax-exempt nonprofit that provides education, advocacy, and support services related to a specific medical condition, aims to help vulnerable individuals or their families, and is focused on patient and caregiver support. The bill requires manufacturers to disclose the name of the patient advocacy organization and the total amount of the payment. This expanded reporting is designed to increase transparency about financial relationships between medical manufacturers and advocacy groups, helping to reveal potential conflicts of interest or undue influence in patient support networks. The bill specifically exempts these new reporting requirements from certain federal paperwork regulations to streamline implementation.

Budget and Finance

https://www.congress.gov/bill/119th-congress/senate-bill/2710/all-info